Literature DB >> 3455829

Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.

S Daenen, E Vellenga, O A van Dobbenburgh, M R Halie.   

Abstract

A patient with acute promyelocytic leukemia (APL) and laboratory evidence of fibrinolysis who could not be treated with aggressive cytostatic regimens because of Aspergillus pneumonia was treated with cis-retinoic acid (RA), a substance that can induce differentiation and maturation of APL cells. After seven weeks of daily oral treatment, he went into complete remission, and signs of coagulopathy disappeared. Meanwhile, the Aspergillus pneumonia could be treated adequately. Based on the experience in this single patient, RA deserves further evaluation in the treatment of APL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455829

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Acute myelogenous leukaemia in children.

Authors:  S O Lie
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

Review 2.  Differentiation therapy of leukemia: 3 decades of development.

Authors:  Daniel Nowak; Daphne Stewart; H Phillip Koeffler
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

3.  Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

Authors:  Yì-Xiáng J Wáng; Fan Xiao
Journal:  Quant Imaging Med Surg       Date:  2015-06

Review 4.  Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction.

Authors:  Junmin Li; Hongming Zhu; Jiong Hu; Jianqing Mi; Saijuan Chen; Zhu Chen; Zhenyi Wang
Journal:  Int J Hematol       Date:  2014-06-18       Impact factor: 2.490

5.  Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse.

Authors:  T Haferlach; H Löffler; B Glass; W Gassmann
Journal:  Clin Investig       Date:  1993-10

6.  A phase 1 and pharmacokinetic study using the aromatic retinoic acid analogue dichloroetretinate (Ro 12-7554).

Authors:  B A Zonnenberg; A von Dijk; C P Vendrik; J H Schornagel; A Struyvenberg
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A.

Authors:  M H Zile; M E Cullum; R U Simpson; A B Barua; D A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation.

Authors:  Guixian Wu; Ting Liu; Han Li; Yafang Li; Dengju Li; Wenhua Li
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

Review 9.  Acute promyelocytic leukemia current treatment algorithms.

Authors:  Musa Yilmaz; Hagop Kantarjian; Farhad Ravandi
Journal:  Blood Cancer J       Date:  2021-06-30       Impact factor: 11.037

Review 10.  Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.

Authors:  P A Marks; R A Rifkind
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.